RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial-Reference-Cited by-同舟云学术

RETRACTED: Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

Published:2007-12 Issue:12 Volume:8 Page:1071-1078
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Bonnefoi Hervé,Potti Anil,Delorenzi Mauro,Mauriac Louis,Campone Mario,Tubiana-Hulin Michèle,Petit Thierry,Rouanet Philippe,Jassem Jacek,Blot Emmanuel,Becette Véronique,Farmer Pierre,André Sylvie,Acharya Chaitanya R,Mukherjee Sayan,Cameron David,Bergh Jonas,Nevins Joseph R,Iggo Richard D

Publisher

Elsevier BV

Subject

Oncology

Reference22 articles.

1. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials;Lancet,2005

2. Selection of adjuvant chemotherapy for treatment of node-positive breast cancer;Trudeau;Lancet Oncol,2005

3. Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer;Chang;Lancet,2003

4. Gene expression profiles in paraffin-embedded core biopsy tissue predict response to chemotherapy in women with locally advanced breast cancer;Gianni;J Clin Oncol,2005

5. Breast cancer molecular subtypes respond differently to preoperative chemotherapy;Rouzier;Clin Cancer Res,2005

Cited by 179 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth;Breast Cancer Research;2024-02-05

2. The Novel Phosphatase NUDT5 is a Critical Regulator of Triple-Negative Breast Cancer Growth;2023-03-10

3. Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer;Clinical Cancer Research;2022-06-02

4. Expression of X-Linked Inhibitor of Apoptosis Protein (XIAP) in Breast Cancer Is Associated with Shorter Survival and Resistance to Chemotherapy;Cancers;2021-06-04

5. Une fraude exemplaire;Bulletin du Cancer;2021-02